Table 2.
Univariate and multivariate Cox regression of NT-proBNP ratio in the total patients and different subgroups.
| Subgroup | Univariable Cox regression | Multivariable Cox regression | |||||
|---|---|---|---|---|---|---|---|
| HR (95% CI) | SE | P | HR (95% CI) | SE | P | ||
| Total COVID-19 patients | Quantile 2 vs quantile 1 | 3.38 (1.73–6.60) | 0.34 | < 0.001 | 3.14 (1.60–6.16) | 0.34 | 0.001 |
| Quantile 3 vs quantile 1 | 9.39 (5.05–17.48) | 0.32 | < 0.001 | 8.82 (4.72–16.49) | 0.32 | < 0.001 | |
| Quantile 4 vs quantile 1 | 22.53 (12.29–41.31) | 0.31 | < 0.001 | 22.83 (12.39–42.05) | 0.31 | < 0.001 | |
| COVID-19 patients in 2020 | Quantile 2 vs quantile 1 | 5.03 (0.62–41.00) | 1.07 | 0.131 | 4.82 (0.58–40.00) | 1.08 | 0.145 |
| Quantile 3 vs quantile 1 | 8.77 (1.15–66.65) | 1.04 | 0.035 | 6.91 (0.88–54.51) | 1.05 | 0.044 | |
| Quantile 4 vs quantile 1 | 44.55 (6.17–321.73) | 1.009 | < 0.001 | 45.76 (6.32–331.64) | 1.01 | < 0.001 | |
| COVID-19 patients in 2022 | Quantile 2 vs quantile 1 | 4.41 (1.94–10.01) | 0.42 | < 0.001 | 4.04 (1.77–9.23) | 0.42 | 0.001 |
| Quantile 3 vs quantile 1 | 13.44 (6.24–28.92) | 0.39 | < 0.001 | 12.06 (5.58–26.09) | 0.39 | < 0.001 | |
| Quantile 4 vs quantile 1 | 21.30 (9.98–45.44) | 0.39 | < 0.001 | 22.22 (10.31–47.91) | 0.39 | < 0.001 | |